Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
5.40
+0.11 (2.08%)
Nov 5, 2026, 3:04 PM CST
Guangdong VTR Bio-Tech Revenue
Guangdong VTR Bio-Tech had revenue of 211.09M CNY in the quarter ending September 30, 2026, with 6.55% growth. This brings the company's total for the last twelve months to 827.06M, down -0.46% year-over-year. In the year 2025, Guangdong VTR Bio-Tech had annual revenue of 832.26M with 0.73% growth. That makes Guangdong VTR Bio-Tech the 21,058th largest company in the world by revenue and 3,868th in China.
Revenue (ttm)
827.06M
Revenue Growth
-0.46%
P/S Ratio
3.14
Revenue / Employee
747.79K
Employees
1,106
Market Cap
2.59B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Guangdong VTR Bio-Tech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 832.26M | 6.05M | 0.73% |
| Dec 31, 2024 | 826.20M | 30.18M | 3.79% |
| Dec 31, 2023 | 796.02M | -377.98M | -32.20% |
| Jan 1, 2023 | 1.17B | -718.15M | -37.95% |
| Jan 1, 2022 | 1.89B | -22.60M | -1.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Universal Biotech | 1.22B |
| Beijing Kawin Technology Share-Holding | 1.21B |
| Zhejiang East Asia Pharmaceutical | 952.80M |
| Landfar Bio-medicine | 748.74M |
| Hubei Goto Biopharm Group | 665.71M |
| Zhejiang Shouxiangu Pharmaceutical | 590.94M |
| Lifecome Biochemistry | 453.12M |
| Guanhao Biotech | 344.85M |